Respiratory Disposables Market Analysis & Forecast: 2026-2033

Respiratory Disposables Market Size and Share Analysis: 2026 - 2033

The global respiratory disposables market size is expected to reach approximately USD 2,350.2 Mn in 2026 and USD 4,350.4 Mn by 2033, growing at a CAGR of 9.8% throughout the forecast period (2026-2033).

Key Takeaways from the Respiratory Disposables Market Report

• Resuscitator remain a highly sought-after type, accounting for about 47.5% of the market share in 2026.
• Hospitals are expected to remain leading end user segment accounting for 50% in the respiratory disposables market revenue in 2026, driven by greater use of ventilators/oxygen delivery systems, and highest patient inflow for acute and chronic respiratory conditions.
• The adults segment registered its dominance over the global respiratory disposables market with share of 55% in 2026.
• North America is projected to dominate the global medical ozone generator industry in 2026, with a share of over 43% due to strong adoption of alternative therapies.

Respiratory Disposables Market Overview

Respiratory disposables are one time-use medical products utilized in ventilation support, respiratory care, airway management and oxygen therapy. These products are non-reusable and sterile and discarded to prevent hospital-acquired infections, cross-contamination, and ensure patient safety. The respiratory disposables market is gaining strategic importance due to rising burden of respiratory diseases such as Acute Respiratory Distress Syndrome (ARDS), Respiratory infections, COPD (Chronic Obstructive Pulmonary Disease), Asthma and Sleep apnea among others. The healthcare operators are increasingly adopting the use of single-use respiratory products because of strong focus on infection prevention & hospital safety. Moreover, due to expansion of critical care infrastructure and ICU, growth of home respiratory care and regulatory push for single-use medical products is driving the growth of the respiratory disposables market.

Current Events and Their Impact on the Respiratory Disposables Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Product Approvals and Launches (2025-2026)

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Respiratory Disposables Market Insights, By Product   - Resuscitator Holds Dominant Product in the Market

Based on product, resuscitator is expected to lead the market, accounting for a revenue share of 47.5% in 2026. Resuscitators are used widely in hospitals, ambulatory surgical centers, emergency medical services, home care, and field scenarios. Hence, the resuscitators are used extensively and has broad application scope compared with more specialized disposables. This broad usage helps capture a larger share of overall respiratory disposables. After the pandemic infection control priorities and stringent hygiene standards have boosted preference for single‑use/ disposable resuscitators to avoid cross‑contamination risk and simplify protocols increasing segment share within the market. Furthermore, ease of use and versatility of resuscitator and regulatory & training support drives the segment growth.

Respiratory Disposables Market Insights, By End User - Hospitals to Remain Leading End Users of Respiratory Disposables

By end user, hospitals segment is slated to account for a prominent market share of 50% in 2026. Due to highest volume of critical respiratory cases that require oxygen therapy, non-invasive ventilation, or mechanical ventilation the patient admission in hospitals increased.

• For instance, in March 2026, according to the U.S. Centers for Disease Control and Prevention (CDC) surveillance reports, ~600,000 hospitalizations occurred in the midpoint of 2024 in the U.S. alone for respiratory disease conditions. The Centers for Disease Control and Prevention's respiratory surveillance indicates that there were 23 million medical visits in 2025 and 710,000 influenza-related hospitalizations for the 2024-2025 season.
• Furthermore, in January 2026, according to the data published by the U.S. Centers for Disease Control and Prevention (CDC), it was estimated that the number of new influenza hospital admissions is between 5,400 and 26,800 patients hospitalized with laboratory-confirmed influenza during the week ending December 27, 2025.

Higher dependence on ventilation and respiratory support equipment and Strong infection-control requirements drive single-use consumption in hospitals, which is a major factor supporting dominance of the hospital segment in the market.

Respiratory Disposables Market Insights, By Patient Group

Based on patient group, adult segment led the global respiratory disposables market with share of 55% in 2026. As the adults shows higher incidence of conditions such as asthma, chronic obstructive pulmonary disease, and pneumonia, the demand for the respiratory consumables rises gradually. Growing aging population, lifestyle risk factors, and higher hospitalization rate further support the dominance of the segment in the market.

• For instance, in March 2026, according to the data published by the Morningside House Senior Living surveillance the number of adults in the U.S. who are 65 years of age or older is expected to reach over 60 million by 2026, according to data and predictions from the CDC and the U.S. Census Bureau for 2024–2026.

Regional Insights

To learn more about this report, Download Free Sample

North America Remains the Market Leader in Respiratory Disposables Adoption

North America is expected to dominate the global respiratory disposables market, accounting for a share of 43% in 2026. Due to higher prevalence of the respiratory infection in the North America region there is increase in the for the respiratory disposables. For instance, in March 2026, according to the data published by the Asthma and Allergy Foundation of America, is has been estimated that asthma is still the most common chronic illness in the United States, affecting approximately 28 million people (about 1 in 12) as of early 2026 and costing the country USD50 billion annually.

Strict infection-control laws favor single-use products and strong reimbursement and home-care support drives the growth of the respiratory disposables market in North America region. Moreover, as North America region has presence of leading manufacturers of innovative respiratory disposables and insurance companies in North America, including government-funded programs like Medicare, cover an extensive product portfolio of respiratory disposables under their policies, which stimulates the growth of the market in the region.

Asia Pacific Respiratory Disposables Market Trends

The countries in Asia like India, China and Southeast Asia, are facing high levels of air pollution, which directly contributes to the increasing incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung infections. Due to higher burden of respiratory diseases in the Asia Pacific region the respiratory disposables market grows at significant rate in the region. Moreover, factors like expanding healthcare infrastructure, government initiatives & healthcare reforms and increased healthcare expenditure and access, drive the growth of the Asia Pacific respiratory disposables market. 

Respiratory Disposables Market Outlook – Country-wise

U.S. Respiratory Disposables Market Forecast

The U.S. country has higher prevalence of chronic respiratory conditions, including pneumonia, asthma, COPD, and sleep apnea. The regulatory bodies in U.S. such as Food and Drug Administration and Centers for Disease Control and Preventions play a significant role in ensuring the safety and effectiveness of respiratory disposables. For instance, in March 2026, the Glenmark Specialty SA, pharmaceutical company reveals that the company has received the United States Food & Drug Administration (U.S. FDA) final approval for the Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation.

In the U.S. country the respiratory care accounts for a large portion of the substantial healthcare expenditures. The Centers for Medicare & Medicaid Services (CMS) estimated that healthcare spending would surpass USD6 trillion by 2028, which will lead to a rise in investment in medical technologies, particularly respiratory disposables. Rising awareness among the U.S. population for the prevention of the chronic respiratory infections, there is a greater push for early diagnosis and continuous monitoring. As a result, respiratory disposables, particularly those utilized in home care settings, are seeing growing adoption, especially in telehealth environments where respiratory monitoring is increasingly integrated into at-home care.

China Respiratory Disposables Market Trends

China country has the large number of ageing population which has observed to increase the demand for the respiratory disposables for preventing the spread of viral infection. China country has strong domestic manufacturing base and broad insurance coverage improves access and repeat consumption. China country leads the Asia Pacific respiratory disposable market due to advanced manufacturing facilities and largest demand base with a very large healthcare delivery and manufacturing system.

Respiratory Disposables Industry News

• In March 2026, LifeVac LLC, medical equipment manufacturing company unveiled that the De Novo classification for LifeVac has been classified under Class II, 21 CFR 874.5400 by the U.S. Food and Drug Administration and formally established the device type “suction anti-choking device as a second-line treatment.
• In October 2025, Cipla, a pharmaceutical company, revealed the plans to introduce respiratory assests by the end of 2026 to strengthen its product portfolio. The company unveiled a broader strategy to introduce seven new products by 2026, including four respiratory assets and three peptides.
• In February 2026, fluidIQ, a MedTech startup company, revealed that the Journal Anesthesiology's photographs in Anesthesiology publication features photographs and a brief essay demonstrating fluidIQ's HOPE inVentsmall resuscitator. fluidIQ is a MedTech startup that is creating fluidics-based respiratory treatments. The magazine features wave patterns that illustrate the performance characteristics of the company's small in-line resuscitator in a clinical setup configuration.

Market Report Scope

Respiratory Disposables Market Drivers

Increasing incidence of chronic respiratory diseases

Growing incidence of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease has risen the demand for the respiratory disposables. For instance, in March 2026, according to the data published by the Elsevier Ltd., it has been estimated that in India asthma is the major chronic health issue, with an estimated 35 million people suffering from the condition. India has a disproportionately heavy burden, accounting for 42% of asthma deaths worldwide and 13% of all asthma cases worldwide.

Respiratory Disposables Market Trends

Shift Toward Remote Monitoring and In-Home Respiratory Care

Due technology advancement and shift towards in-home respiratory care the treatment of chronic pulmonary obstructive diseases can be provided outside the hospitals. According to NICE's 2024 assessment, several COPD remote-monitoring devices are utilized to facilitate earlier discharge and prevent needless admissions. These devices help to monitor and check symptoms, blood oxygen levels, and decline at home. As a result, the usage of home respiratory supplies, such as nasal cannulas, masks, and oxygen-delivery devices, is increasing.

Respiratory Disposables Market Opportunities

Increasing Adoption of Inorganic Growth Strategies Like Collaborations with OEMs & Service Providers

The key players operating in the market are adopting the inorganic growth strategies like partnership and collaboration with OEMs & service providers which has estimated to create the significant opportunity for the growth of the respiratory disposables market in the near future. For instance, in December 2025, Teleflex Incorporated, a company that supplies medical technology, signed the agreement to sell its Acute Care, Interventional Urology, and OEM businesses to two buyers: Intersurgical Ltd. for Acute Care and Interventional Urology, and Montagu and Kohlberg for OEM, for a total of USD 2.03 billion in cash, subject to certain closing adjustments.

Furthermore, in January 2026, ENT UK, entered the strategic alliance with Ambu, global medical technology company, to expand the adoption of its single-use airway management and respiratory products, including breathing accessories and single-use airway management. This strategic partnership aims to provide valuable opportunities to support the development of community-focused ENT services. To this end, Ambu and ENT UK will team-up on a dedicated discussion group at the ENT UK Innovation Forum in October 2026. The group's focus will be on exploring the design, implementation, and expansion of community ENT models.

Analyst Opinion (Expert Opinion)

• Due to increasing air pollution, there is rise in incidence of chronic respiratory diseases, such as asthma, COPD, respiratory infection. There is even increase in reliance on oxygen therapy after the pandemic situation. Healthcare providers and hospitals are increasingly relying on single-use respiratory consumables including breathing circuits, oxygen masks, and nebulizer kits to ensure patient safety, improve treatment efficiency, and minimize the risk of hospital-acquired infections.
• Increasing hospital expenditure and healthcare facilities is supporting the growth of the respiratory disposables market. Increasing technology advancement and regulatory support has driven the growth of the market over the forecast period.
• Post-discharge from hospitals, there is high demand for products like aerosol drug administration, ventilation, and oxygen delivery. According to the analysts opinion, shift towards in-home care and respiratory monitoring systems has driven the growth of the market over the forecast period. In-home care solutions are becoming increasingly popular as part of integrated respiratory care strategies.
• Infection prevention has become the top most priority in healthcare facilities post-pandemic. According to the expert’s opinion, the single-use respiratory products help minimize cross-contamination between patients and healthcare workers. As a result, intensive care units and hospitals are increasingly adopting disposable respiratory accessories such As filters, ventilator circuits and tubing systems. 

Respiratory Disposables Market Segmentation

• By Product Insights ( Revenue, USD Mn, 2020 - 2033)
  • Laryngoscope
  • Tubes
  • Breathing Bag
  • Resuscitator
  • Others
• By End User Insights ( Revenue, USD Mn, 2020 - 2033)
  • Hospitals,
  • Nursing Homes
  • Clinics
  • Trauma Centres
  • Homecare
• By Patient Group Insights ( Revenue, USD Mn, 2020 - 2033)
  • Adult
  • Neonatal & Pediatric
  • Geriatric
• By Region Insights ( Revenue, USD Mn, 2020 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Key Players
  • Medtronic
  • Fisher & Paykel Healthcare
  • Teleflex Incorporated
  • Drägerwerk AG & Co. KGaA
  • ResMed
  • Getinge AB
  • Smiths Medical / Smiths Group
  • Air Liquide
  • Invacare Corporation
  • Hamilton Medical
  • Ambu A/S
  • Intersurgical Ltd.
  • Medline Industries
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company (BD)

Sources

Primary Research interviews

• Interviews with R&D heads, product managers, and clinical users in hospitals to discuss product needs, performance, and regulatory challenges in respiratory disposables.
• Insights from procurement managers on purchasing trends, supplier relationships, and factors influencing disposable respiratory product adoption.
• Discussions with biomedical engineers specializing in ozone therapy to understand integration, quality, safety, and cost-efficiency of respiratory disposables.

Databases

• PubMed — biomedical literature and clinical studies
• IEEE Xplore — technical papers on medical device technology
• ClinicalTrials.gov — registry of ongoing and completed clinical studies involving ozone therapy
• Scopus — multidisciplinary research abstracts and citations

Magazines

• Medical Device & Diagnostic Industry (MD+DI)
• RT: For Decision Makers in Respiratory Care
• MassDevice
• MedTech Dive
• Medical Design & Outsourcing
• MedTech Intelligence
• Health Management Technology Magazine

Journals

• Journal of Medical Devices
• International Journal of Medical Sciences
• Respiratory Care
• European Respiratory Journal
• ERJ Open Research
• BMJ Open Respiratory Research
• Journal of Aerosol Medicine and Pulmonary Drug Delivery
• Indian Journal of Respiratory Care

Newspapers

• The New York Times — Health Section
• The Guardian — Health & Science
• The Hindu — Health and Technology
• The Economic Times — ETHealthworld / Medical Devices
• Times of India — Science & Health
• Reuters — Healthcare & Pharmaceuticals

Associations

• American Association for Respiratory Care (AARC)
• European Respiratory Society (ERS)
• British Thoracic Society (BTS)
• Association of Respiratory Technology & Physiology (ARTP)
• International Society for Aerosols in Medicine (ISAM)

Public Domain sources:

• U.S. Food and Drug Administration (FDA) — Respiratory Devices
• European Commission — EUDAMED / Medical Devices
• World Health Organization (WHO) — Medical Devices publications
• WHO MeDevIS (Medical Devices Information System)
• Central Drugs Standard Control Organization (CDSCO), India — Medical Device & Diagnostics
• Medical Devices Rules, 2017 (India)

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of information for last 8 years